rosiglitazone has been researched along with berberine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Zhou, JY; Zhou, SW | 2 |
| Chen, FL; Hu, RM; Li, LX; Liang, WC; Liu, Y; Wang, XC; Yang, YH; Yang, ZH; Zhou, WB | 1 |
| Chen, Y; Li, Y; Sun, C; Wang, Y; Wen, Y | 1 |
| Jiang, JD; Kong, WJ; Pan, HN; Song, DQ; Wang, SK; Wang, YM; Wang, ZZ; Wei, J; Wu, JD; Xue, R; Zhang, H; Zhao, W; Zhou, ZX | 1 |
| Fan, MS; Huang, CG; Li, ZX; Sun, ZL; Tang, YH | 1 |
| Han, Y; Kim, MJ; Lee, KY | 1 |
| Kimura, H; Koketsu, M; Nishina, A; Phay, N; Sato, D; Ukiya, M | 1 |
| Cai, L; Guan, X; Hu, X; Jiang, L; Zhang, L | 1 |
1 trial(s) available for rosiglitazone and berberine
| Article | Year |
|---|---|
Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.
Topics: Aged; Berberine; Blood Glucose; Cell Line; Diabetes Mellitus, Type 2; Female; Gene Expression; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Liver Diseases; Male; Metformin; Middle Aged; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, Insulin; RNA, Messenger; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2010 |
9 other study(ies) available for rosiglitazone and berberine
| Article | Year |
|---|---|
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Effect of berberine on PPARalpha/delta/gamma expression in type 2 diabetic rat retinae.
Topics: Animals; Berberine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Fenofibrate; Hypoglycemic Agents; Male; PPAR alpha; PPAR delta; PPAR gamma; Rats; Rats, Wistar; Retina; Rosiglitazone; Thiazolidinediones | 2007 |
Berberine inhibits the expression of TNFalpha, MCP-1, and IL-6 in AcLDL-stimulated macrophages through PPARgamma pathway.
Topics: Anilides; Atherosclerosis; Berberine; Cell Line; Chemokine CCL2; Humans; Hypoglycemic Agents; Interleukin-6; Lipoproteins, LDL; Macrophages; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2008 |
Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions.
Topics: Anilides; Berberine; Blotting, Western; Carnitine O-Palmitoyltransferase; CD36 Antigens; Cell Line; Cell Survival; Fatty Acids; Fatty Acids, Nonesterified; Gene Expression; Glucose; Humans; Hypoglycemic Agents; Insulin Resistance; Muscle Fibers, Skeletal; PPAR alpha; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2009 |
Protective effect of berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver.
Topics: Animals; Antioxidants; Berberine; Coptis; Cyclin T; Cyclin-Dependent Kinase 9; Diabetes Mellitus, Experimental; Diet; Drugs, Chinese Herbal; Enzymes; Fenofibrate; Hyperlipidemias; Hypoglycemic Agents; Hypolipidemic Agents; Lipid Peroxidation; Liver; Male; Malondialdehyde; Phytotherapy; Positive Transcriptional Elongation Factor B; Rats; Rats, Wistar; Rhizome; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Up-Regulation | 2011 |
Anti-diabetic effects of TongGuanWan, a Chinese traditional herbal formula, in C57BL/KsJ-db/db mice.
Topics: Acrolein; Administration, Oral; Animals; Berberine; Blood Glucose; Body Weight; Cholesterol, HDL; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Glucose Intolerance; Glycated Hemoglobin; Hypoglycemic Agents; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Knockout; Phytotherapy; Rosiglitazone; Saponins; Thiazolidinediones; Triglycerides; Xanthones | 2012 |
Berberine derivative, Q8, stimulates osteogenic differentiation.
Topics: Animals; Berberine; Cell Differentiation; Cell Line; Glycogen Synthase Kinase 3 beta; Mice; Myoblasts; Osteoblasts; Osteogenesis; Osteoporosis; Phosphorylation; PPAR gamma; Rosiglitazone | 2018 |
(-)-
Topics: 3T3-L1 Cells; Adipogenesis; Adiponectin; Animals; Berberine; Cell Death; Cell Membrane; Glucose Transporter Type 4; Lignans; Lipid Metabolism; MAP Kinase Signaling System; Mice; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Plant Extracts; PPAR gamma; Protein Kinase Inhibitors; Rosiglitazone; Signal Transduction; Up-Regulation; Vitex | 2019 |
A New Co-Crystal of Synthetic Drug Rosiglitazone with Natural Medicine Berberine: Preparation, Crystal Structures, and Dissolution.
Topics: Berberine; Crystallography, X-Ray; Hydrogen Bonding; Molecular Conformation; Quantum Theory; Rosiglitazone; Solubility; Static Electricity | 2020 |